Cardlytics, Inc. announced consolidated impairment charge for the second quarter ended June 30, 2022. For the quarter, the company reported Goodwill impairment of $83,149,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.31 USD | +6.26% | +0.74% | +33.66% |
04-25 | Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing | MT |
04-09 | Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.66% | 593M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.55B | |
+17.75% | 41.41B | |
+55.21% | 35.63B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- CDLX Stock
- News Cardlytics, Inc.
- Cardlytics, Inc. Announces Consolidated Impairment Charge for the Second Quarter Ended June 30, 2022